Survival advantage in patients with human papillomavirus‐driven oropharyngeal cancer and variation by demographic characteristics and serologic response: Findings from Head and Neck 5000

This is the authors' abstract. We don't add key points for this paper.

HPV status confers a survival advantage across all groups. This survival advantage is more marked for younger patients. The HPV antibody pattern, but not the antibody level, may also affect survival.